The principal business address of the Reporting Persons is as follows: 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, DC 20004.

Not applicable.

During the last five years, the Reporting Persons have not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of which such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

During the last five years, the Reporting Persons have not been convicted in any criminal proceedings (excluding traffic violations or similar misdemeanors).

Not applicable. In accordance with the provisions of General Instruction C to Schedule 13D, information concerning the general partners, executive officers, board of directors and each person controlling the Reporting Persons, as applicable (collectively, the "Listed Persons"), required by Item 2 of Schedule 13D is provided on Schedule 1 and is incorporated by reference herein. To the Reporting Persons' knowledge, none of the persons listed on Schedule 1 as a director or executive officer of ASPI or QLE has been, during the last five years, (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

To the extent required by Item 3, the information contained in Item 4 is incorporated herein by reference.

On August 29, 2025, Quantum Leap Energy LLC ("QLE"), a wholly owned subsidiary of ASP Isotopes Inc., became a controlling shareholder of Skyline Builders Group Holding Limited, a company incorporated under the laws of the Cayman Islands ("SKBL" or the "Issuer") with its Class A Ordinary Shares listed on The Nasdaq Stock Market LLC under the symbol "SKBL". QLE intends to use SKBL to pursue opportunities to acquire assets in the critical materials supply chain that QLE believes will help the United States and QLE secure important feedstocks that are vital to the security of the United States and long-term growth of QLE. SKBL Share Capital Structure. SKBL has a dual class ordinary share structure. SKBL's Ordinary Shares are divided into Class A Ordinary Shares ("Class A Ordinary Shares") and Class B Ordinary Shares ("Class B Ordinary Shares"). Each Class A Ordinary Share entitles the holder thereof to one (1) vote on all matters subject to vote at general meetings of SKBL, and each Class B Ordinary Share entitles the holder thereof to twenty (20) votes on all matters subject to vote at general meetings of SKBL. In no event shall Class A Ordinary Shares be convertible into Class B Ordinary Shares. In no event shall Class B Ordinary Shares be convertible into Class A Ordinary Shares. QLE's Purchase of Controlling Interest in SKBL. On August 27, 2025, Supreme Development (BVI) Holdings Limited ("SD"), SKBL's previous controlling shareholder and a company beneficially owned by Mr. Ngo Chiu Lam, SKBL's Chief Executive Officer, entered into a definitive securities purchase agreement with QLE pursuant to which SD transferred and sold to QLE all 1,995,000 issued and outstanding Class B Ordinary Shares ("Class B Share Transfer"), for the aggregate purchase price of $1,000,000. As a holder of Class B Ordinary Shares, QLE is entitled to cast 20 votes per share and to vote together with holders of Class A Ordinary Shares on all matters submitted to the vote of shareholders of SKBL. SKBL Private Placement. On August 29, 2025, SKBL closed a private placement (the "Private Placement") pursuant to which SKBL issued and sold (i) 1,359,314 Class A Ordinary Shares, (ii) prefunded warrants to purchase 22,990,000 Class A Ordinary Shares, at an exercise price of $0.0001 per share ("Prefunded Warrant"), (iii) Class A Ordinary Share Purchase Warrant As to purchase up to 24,349,314 Class A Ordinary Shares, at an exercise price of $0.60 per share ("A Warrant"), (iv) Class A Ordinary Share Purchase Warrant Bs to purchase up to 24,349,314 Class A Ordinary Shares, at an exercise price of $0.65 per share ("B Warrant" and together with Prefunded Warrant and A Warrant, "Warrants"), and (v) placement agent warrants to purchase 1,947,945 Class A Ordinary Shares issued to the placement agents of the Private Placement as compensation. SKBL received aggregate gross proceeds of $17,775,000 from the Private Placement, before deducting fees and offering expenses. In the Private Placement, QLE purchased: (i) 454,794 Class A Ordinary Shares, (ii) a Prefunded Warrant to purchase 1,600,000 Class A Ordinary Shares, (iii) a A Warrant to purchase 2,054,794 Class A Ordinary Shares, and (iv) a B Warrant to purchase 2,054,794 Class A Ordinary Shares, for the aggregate purchase price of $1,500,000, pursuant to a Securities Purchase Agreement with SKBL, dated as of August 27, 2025 (the "Purchase Agreement"). Each Warrant is immediately exercisable and entitles the holder to acquire Class A Ordinary Shares for a period of five years following August 29, 2025. SKBL Share Retirement. Approximately $7,000,000 of the proceeds from the Private Placement was used to retire 18,500,000 Class A Ordinary Shares owned by SD, SKBL's previous controlling shareholder (the "Share Retirement"). QLE as Controlling Shareholder. After giving effect to the Class B Share Transfer, the Private Placement and the Share Retirement, QLE became the holder of 79.14% of the aggregate voting power represented by all outstanding Class A Ordinary Shares and Class B Ordinary Shares, and thereby gaining control over SKBL. Director Appointments. Effective on September 18, 2025, the Board of Directors (the "Board") of the Issuer approved the appointments of Dr. Ryno Pretorius ("Dr. Pretorius") and Mr. Jacob Rowe ("Mr. Rowe") as independent directors of the Issuer, to fill the vacancies resulting from the resignations of former directors Ms. Li and Mr. Cha. Dr. Pretorius is the Chief Executive Officer of Quantum Leap Energy LLC and Mr. Rowe is Vice President of Business Development and Investor Relations at ASP Isotopes Inc. Plans or Proposals. The Reporting Persons do not have any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. The Reporting Persons have acquired the shares reported herein for investment purposes. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer's financial position and investment strategy, the price levels of the Issuer's ordinary shares, conditions in the securities markets and general economic and industry conditions, the Reporting Persons and their representatives may in the future take such actions with respect to his investment in the Issuer as he deems appropriate. Among other things, the Reporting Persons may introduce the Issuer to potential candidates for a business combination, or propose one or more business combinations with potential candidates, which may include candidates that are affiliates of the Reporting Persons or in which the Reporting Persons otherwise have an equity or other interest. In addition, representatives of the Reporting Persons will be involved in negotiations in connection with any prospective business combination of the Issuer, the decisions of the board of directors related to any such business combination, and any matters to be presented to the Issuer's shareholders in connection therewith. The Reporting Persons are expected to be involved in reviewing possible transactions involving the Issuer and identifying candidates to serve on the board of directors. As such, the Reporting Persons may be involved in transactions of the sort described in clauses (a) through (j) of Item 4 of Schedule 13D. The Reporting Persons may purchase ordinary shares of the Issuer and/or rights in privately negotiated transactions or in the open market either prior to, in connection with or following the completion of the Issuer's initial business combination. The purpose of any such purchases of shares could be to satisfy a closing condition in an agreement with a target that requires the Issuer to have a minimum net worth or a certain amount of cash at the closing of the Issuer's initial business combination, where it appears that such requirement would otherwise not be met. The purpose of any such purchases of rights could be to reduce the number overhang of the rights on the outstanding share capital. Any such purchases of the Issuer's securities may result in the completion of an initial business combination that may not otherwise have been possible.

The information set forth in the facing pages of this Schedule 13D with respect to the beneficial ownership of the Reporting Persons is incorporated by reference into this Item 5. The aggregate number of Class A Shares owned by the Reporting Persons is 6,164,382 shares, which includes an aggregate of 5,709,588 Class A Shares issuable upon the exercise of Warrants held by the Reporting Persons which may be exercised at any time and from time to time for a period of five years following August 29, 2025 at the option of the Reporting Persons. The Reporting Persons' aggregate percentage of beneficial ownership is approximately 36.7%. References to percentage ownership of Class A Shares in this Schedule 13D are based upon the 11,089,314 Class A Shares outstanding as reported by the Issuer in its Registration Statement on Form F-1 filed on September 10, 2025.

The Reporting Persons have sole voting and dispositive power over the Class A Shares reported in this Schedule 13D.

Except for the transactions described in Item 4 of this Schedule 13D, none of the Reporting Persons or, to the Reporting Persons' knowledge, the Lister Persons has engaged in any transaction during the past 60 days involving the ordinary shares of the Issuer.

To the best knowledge of the Reporting Persons, no one other than the Reporting Persons, or the affiliates of the Reporting Persons, is known to have the right to receive, or the power to direct the receipt of, dividends from, or proceeds from the sale of, the Class A Shares reported herein as beneficially owned by the Reporting Persons.

Not applicable.

The information set forth in Item 4 above is hereby incorporated by reference into this Item 6. As described above, based on QLE's ownership of all 1,995,000 issued and outstanding Class B Ordinary Shares, QLE is a controlling shareholder of the Issuer. Effective on September 18, 2025, the Board of Directors (the "Board") of the Issuer approved the appointments of Dr. Ryno Pretorius ("Dr. Pretorius") and Mr. Jacob Rowe ("Mr. Rowe") as independent directors of the Issuer, to fill the vacancies resulting from the resignations of former directors Ms. Li and Mr. Cha. Dr. Pretorius is the Chief Executive Officer of QLE and Mr. Rowe is Vice President of Business Development and Investor Relations at ASP Isotopes Inc.

The documents listed below are filed as exhibits (incorporated by reference to the exhibits to the Issuer's Current Report on Form 6-K filed with the Securities and Exchange Commission on September 2, 2025). Exhibit No. Description 1 Securities Purchase Agreement 2 Form of Pre-Funded Warrant 3 Form of Class A Ordinary Share Purchase Warrant A 4 Form of Class A Ordinary Share Purchase Warrant B 5 Registration Rights Agreement